Skip to main navigation Skip to search Skip to main content

Bioequivalence Study of Two 50 mg Desvenlafaxine Extended Release Formulations: A Randomized, Single-Dose, Open-Label, Two Periods, Crossover Study

  • Mauricio Vargas Malagon (First Author)

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Translated title of the contributionBioequivalence Study of Two 50 mg Desvenlafaxine Extended Release Formulations: A Randomized, Single-Dose, Open-Label, Two Periods, Crossover Study
Original languageUndefined/Unknown
Pages (from-to)115-118
Number of pages3
JournalBioequivalence ; Bioavailability
DOIs
StatePublished - 1 Jul 2014

Article Classification

  • Full research article

Indexación Internacional (Artículo)

  • Ninguno

Scopus-Q Quartil

  • Q3

ISI- Q Quartil

  • Ninguno

Categoría Publindex

  • B

Cite this